Search Results - Christopher T. Gubish
- Showing 1 - 7 results of 7
-
1
HGF-independent potentiation of EGFR action by c-Met by Austin Dulak, Christopher T. Gubish, Laura P. Stabile, C Henry, Jill M. Siegfried
Published 2011Artigo -
2
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung Cancer by Jill M. Siegfried, Christopher T. Gubish, Mary E. Rothstein, Cassandra L. Henry, Laura P. Stabile
Published 2012Artigo -
3
-
4
-
5
-
6
c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met by Laura P. Stabile, Guoqing He, Vivian Wai Yan Lui, Sufi M. Thomas, Cassandra L. Henry, Christopher T. Gubish, Sonali Joyce, Kelly M. Quesnelle, Jill M. Siegfried, Jennifer R. Grandis
Published 2012Artigo -
7
HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer by Lynn M. Knowles, Laura P. Stabile, Ann Marie Egloff, Mary E. Rothstein, Sufi M. Thomas, Christopher T. Gubish, Edwina C. Lerner, Raja R. Seethala, Shinsuke Suzuki, Kelly M. Quesnelle, Sarah Morgan, Robert L. Ferris, Jennifer R. Grandis, Jill M. Siegfried
Published 2009Artigo
Search Tools:
Related Subjects
Receptor
Cancer research
Internal medicine
Medicine
Biology
Cancer
Epidermal growth factor receptor
Hepatocyte growth factor
Tyrosine kinase
C-Met
Cell biology
EGFR inhibitors
Genetics
Head and neck cancer
Head and neck squamous-cell carcinoma
Protein kinase B
Signal transduction
Breast cancer
Cell growth
Cytokine
Endocrinology
Lung cancer
Paracrine signalling
Phosphorylation
Proto-oncogene tyrosine-protein kinase Src
Tyrosine phosphorylation
Tyrosine-kinase inhibitor
Antiestrogen
Biochemistry
Blockade